We are live on ! Find out more
LWCFA

Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 3.26%
This Fund
S&P 500
This Quarter Est. Return
+2.4%
1 Year Est. Return
+3.26%
3 Year Est. Return
+43.63%
5 Year Est. Return
+56.22%
10 Year Est. Return
+342.64%
AUM
$4.35B
AUM Growth
+$111M
Cap. Flow
+$33.2M
Cap. Flow %
0.76%
Top 10 Hldgs %
35.73%
Holding
670
New
43
Increased
121
Reduced
152
Closed
29

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$21.5M
2
ABT icon
Abbott
ABT
+$9.15M
3
CTSH icon
Cognizant
CTSH
+$6.16M
4
OXY icon
Occidental Petroleum
OXY
+$4.56M
5
DHR icon
Danaher
DHR
+$4.5M

Sector Composition

Rank Sector Weight
1 Technology 19.91%
2 Healthcare 19.18%
3 Consumer Staples 14.39%
4 Consumer Discretionary 10.17%
5 Industrials 9.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTB icon
326
M&T Bank
MTB
$36.6B
$99K ﹤0.01%
840
TV icon
327
Televisa
TV
$1.49B
$96K ﹤0.01%
3,700
TOWN icon
328
Towne Bank
TOWN
$3.49B
$94K ﹤0.01%
4,320
QTWO icon
329
Q2 Holdings
QTWO
$3.9B
$93K ﹤0.01%
3,330
+830
+33% +$20.8K
APH icon
330
Amphenol
APH
$210B
$92K ﹤0.01%
6,400
ET icon
331
Energy Transfer Partners
ET
$72.1B
$92K ﹤0.01%
6,400
AVY icon
332
Avery Dennison
AVY
$13.7B
$90K ﹤0.01%
1,200
IWV icon
333
iShares Russell 3000 ETF
IWV
$20.4B
$90K ﹤0.01%
725
BALL icon
334
Ball Corp
BALL
$16.4B
$89K ﹤0.01%
2,450
CSLT
335
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$87K ﹤0.01%
22,000
BMRN icon
336
BioMarin Pharmaceuticals
BMRN
$13.6B
$86K ﹤0.01%
1,100
REGN icon
337
Regeneron Pharmaceuticals
REGN
$82.2B
$86K ﹤0.01%
245
SIRI icon
338
SiriusXM
SIRI
$9.59B
$84K ﹤0.01%
2,127
VSS icon
339
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$12B
$84K ﹤0.01%
900
WTRG icon
340
Essential Utilities
WTRG
$11.3B
$84K ﹤0.01%
2,342
LQD icon
341
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.7B
$83K ﹤0.01%
675
-40
-6% -$4.8K
STKL
342
DELISTED
SunOpta
STKL
$83K ﹤0.01%
19,855
-13,565
-41% -$62.7K
MANH icon
343
Manhattan Associates
MANH
$11.2B
$82K ﹤0.01%
1,280
+280
+28% +$17.4K
UTG icon
344
Reaves Utility Income Fund
UTG
$3.68B
$81K ﹤0.01%
2,500
ETP
345
DELISTED
Energy Transfer Partners L.p.
ETP
$80K ﹤0.01%
2,090
-1,000
-32% -$35.8K
IJH icon
346
iShares Core S&P Mid-Cap ETF
IJH
$128B
$79K ﹤0.01%
2,660
+300
+13% +$8.8K
BAX icon
347
Baxter International
BAX
$13.9B
$77K ﹤0.01%
1,713
+213
+14% +$9.34K
CAT icon
348
Caterpillar
CAT
$393B
$77K ﹤0.01%
1,010
MTUS icon
349
Metallus
MTUS
$900M
$77K ﹤0.01%
8,000
MMP
350
DELISTED
Magellan Midstream Partners, L.P.
MMP
$76K ﹤0.01%
1,000

Similar funds

Loring Wolcott & Coolidge Fiduciary Advisors's Q2 2016 Portfolio in Review

As of Q2 2016, Loring Wolcott & Coolidge Fiduciary Advisors held 670 positions worth $4.35B, up 2.6% from $4.24B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Loring Wolcott & Coolidge Fiduciary Advisors's Q2 2016 filing shows 43 new, 121 increased, 152 reduced and 29 closed positions. Its largest new stake was Euronet Worldwide: 8,080 shares worth $559K. The largest sale was Fiserv Inc, an estimated $10.3M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Loring Wolcott & Coolidge Fiduciary Advisors's largest Q2 2016 buy was Euronet Worldwide: 8,080 shares worth $559K.
  • Loring Wolcott & Coolidge Fiduciary Advisors added most to Walt Disney in Q2 2016, an estimated $21.5M increase.
  • Loring Wolcott & Coolidge Fiduciary Advisors's biggest Q2 2016 reduction was Fiserv Inc, cutting an estimated $10.3M.
  • Loring Wolcott & Coolidge Fiduciary Advisors fully exited JARDEN CORPORATION in Q2 2016, selling an estimated $624K.
  • Loring Wolcott & Coolidge Fiduciary Advisors's ten largest holdings make up 36% of its $4.35B portfolio in Q2 2016.
  • Loring Wolcott & Coolidge Fiduciary Advisors opened 43 new positions and closed 29 in Q2 2016.
  • Loring Wolcott & Coolidge Fiduciary Advisors's portfolio value rose 2.6% quarter-over-quarter to $4.35B.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2016, filed 11 Jul 2016.